USRE38155E1 - Weight reduction method for dogs and other pets - Google Patents
Weight reduction method for dogs and other pets Download PDFInfo
- Publication number
- USRE38155E1 USRE38155E1 US09/975,334 US97533401A USRE38155E US RE38155 E1 USRE38155 E1 US RE38155E1 US 97533401 A US97533401 A US 97533401A US RE38155 E USRE38155 E US RE38155E
- Authority
- US
- United States
- Prior art keywords
- simmondsin
- weight
- dog
- food
- dogs
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000000034 method Methods 0.000 title claims abstract description 9
- 239000013585 weight reducing agent Substances 0.000 title abstract description 21
- 241000282472 Canis lupus familiaris Species 0.000 title description 54
- KURSRHBVYUACKS-XGYNEUJOSA-N Simmondsin Chemical compound N#C\C=C/1[C@H](O)[C@@H](OC)[C@@H](OC)C[C@H]\1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 KURSRHBVYUACKS-XGYNEUJOSA-N 0.000 claims abstract description 56
- 235000013305 food Nutrition 0.000 claims abstract description 52
- KURSRHBVYUACKS-UHFFFAOYSA-N Simmondsin Natural products N#CC=C1C(O)C(OC)C(OC)CC1OC1C(O)C(O)C(O)C(CO)O1 KURSRHBVYUACKS-UHFFFAOYSA-N 0.000 claims abstract description 51
- 239000000203 mixture Substances 0.000 claims abstract description 22
- 238000012423 maintenance Methods 0.000 claims abstract description 4
- -1 cyanomethylene glycosides Chemical class 0.000 claims description 4
- GWXJMPVVJCHQIB-NSQTZXJSSA-N [(2r,3r,4s,5s,6r)-2-[(1r,2z,3s,4r,5s)-2-(cyanomethylidene)-3-hydroxy-4,5-dimethoxycyclohexyl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl] (z)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate Chemical group N#C\C=C/1[C@H](O)[C@@H](OC)[C@@H](OC)C[C@H]\1O[C@H]1[C@H](OC(=O)\C=C/C=2C=C(OC)C(O)=CC=2)[C@@H](O)[C@H](O)[C@@H](CO)O1 GWXJMPVVJCHQIB-NSQTZXJSSA-N 0.000 claims description 3
- 229930182470 glycoside Natural products 0.000 claims description 3
- 230000004580 weight loss Effects 0.000 claims 1
- 241000221095 Simmondsia Species 0.000 abstract description 42
- 235000004433 Simmondsia californica Nutrition 0.000 abstract description 42
- 235000012054 meals Nutrition 0.000 abstract description 34
- 230000002459 sustained effect Effects 0.000 abstract description 5
- 235000005911 diet Nutrition 0.000 description 41
- 230000037213 diet Effects 0.000 description 34
- 230000000694 effects Effects 0.000 description 33
- 241001465754 Metazoa Species 0.000 description 23
- 208000008589 Obesity Diseases 0.000 description 19
- 235000012631 food intake Nutrition 0.000 description 19
- 235000020824 obesity Nutrition 0.000 description 19
- 230000037406 food intake Effects 0.000 description 17
- 230000009467 reduction Effects 0.000 description 12
- 230000037396 body weight Effects 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 241000700159 Rattus Species 0.000 description 7
- 230000000378 dietary effect Effects 0.000 description 7
- 229940079593 drug Drugs 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 239000000835 fiber Substances 0.000 description 6
- 230000007423 decrease Effects 0.000 description 5
- 235000019197 fats Nutrition 0.000 description 5
- 230000002265 prevention Effects 0.000 description 5
- 230000009469 supplementation Effects 0.000 description 5
- 239000006227 byproduct Substances 0.000 description 4
- 230000003247 decreasing effect Effects 0.000 description 4
- 208000031648 Body Weight Changes Diseases 0.000 description 3
- 206010033307 Overweight Diseases 0.000 description 3
- 230000004579 body weight change Effects 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 235000019750 Crude protein Nutrition 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 244000044822 Simmondsia californica Species 0.000 description 2
- 241000209140 Triticum Species 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 238000012937 correction Methods 0.000 description 2
- 235000019784 crude fat Nutrition 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 230000035558 fertility Effects 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000005802 health problem Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 235000021049 nutrient content Nutrition 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000002000 scavenging effect Effects 0.000 description 2
- 230000003068 static effect Effects 0.000 description 2
- 230000002747 voluntary effect Effects 0.000 description 2
- MRQYIJOEUFLPMV-ADMGTIFDSA-N (2Z)-2-[(2S,3S,4S,6R)-2,3,4-trihydroxy-6-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxycyclohexylidene]acetonitrile Chemical compound OC[C@H]1O[C@@H](O[C@@H]2C[C@H](O)[C@H](O)[C@@H](O)\C2=C\C#N)[C@H](O)[C@@H](O)[C@@H]1O MRQYIJOEUFLPMV-ADMGTIFDSA-N 0.000 description 1
- 241000282465 Canis Species 0.000 description 1
- 208000027219 Deficiency disease Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 235000019733 Fish meal Nutrition 0.000 description 1
- 108010068370 Glutens Proteins 0.000 description 1
- 108010073032 Grain Proteins Proteins 0.000 description 1
- 206010053759 Growth retardation Diseases 0.000 description 1
- 235000019735 Meat-and-bone meal Nutrition 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 241000283222 Physeter catodon Species 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 235000019764 Soybean Meal Nutrition 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000002917 arthritic effect Effects 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 235000019577 caloric intake Nutrition 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000004464 cereal grain Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000020940 control diet Nutrition 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 235000018823 dietary intake Nutrition 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 229940030606 diuretics Drugs 0.000 description 1
- 235000005686 eating Nutrition 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 239000004467 fishmeal Substances 0.000 description 1
- 235000021312 gluten Nutrition 0.000 description 1
- 231100000001 growth retardation Toxicity 0.000 description 1
- 230000008821 health effect Effects 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000031891 intestinal absorption Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000037323 metabolic rate Effects 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 208000019180 nutritional disease Diseases 0.000 description 1
- 239000004465 oilseed meal Substances 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 229940116540 protein supplement Drugs 0.000 description 1
- 235000005974 protein supplement Nutrition 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 239000004455 soybean meal Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000005495 thyroid hormone Substances 0.000 description 1
- 229940036555 thyroid hormone Drugs 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000008280 toxic mechanism Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 239000010698 whale oil Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/163—Sugars; Polysaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
- A23K50/42—Dry feed
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P60/00—Technologies relating to agriculture, livestock or agroalimentary industries
- Y02P60/80—Food processing, e.g. use of renewable energies or variable speed drives in handling, conveying or stacking
- Y02P60/87—Re-use of by-products of food processing for fodder production
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S426/00—Food or edible material: processes, compositions, and products
- Y10S426/805—Pet food for dog, cat, bird, or fish
Definitions
- Obesity is the most common nutritional disease of companion pets such as dogs and cats in an affluent society. It in fact exceeds by far all deficiency diseases combined. Obesity generally is considered present when body weight of the companion pet is 15% or more greater than optimum, which is the point at which health problems begin increasing with increasing weight. It has, for example, been reported that in affluent societies from 24% to 44% of the dogs are obese. Generally speaking, the incidence of obesity in companion pets increases with the age of the pet. Similar to humans, as the animals age body fat increases, and the amount of lean body mass decreases. For dogs particularly, obesity is more common in females than males up to age 12 years.
- the only successful way for reducing companion animals is a drastic food intake reduction.
- the companion pets often scavenge and/or beg for food because of the sensation of constant hunger.
- the animal finds additional food, or pet owners feed the animal to stop the begging with the result being that no weight reduction occurs.
- drugs have been used in the treatment of obesity in mammals, including companion pets. These include drugs which decrease appetite such as amphetamines, drugs which cause nausea, decrease intestinal absorption, or increase metabolic rate such as thyroid hormones and finally, drugs which either tranquilize or act as diuretics. None of the above have been generally effective. They often cause side effects, and tests of most have shown that such drugs are not only expensive, but ineffective in that when free choice fed with food, the animals often tend to avoid the food that contains the drug.
- part of the invention is a method of weight reduction and obesity prevention of companion pets by adding pet food that contains the above-defined range of simmondsin activity, contributed by simmondsin analogues or mixtures thereof such as that synthesized or derived from jojoba seeds or defatted jojoba seed meal, and thereafter feeding the pet food to a companion pet on a regular and sustained basis until sufficient weight reduction occurs, and obesity occurrence or recurrence is prevented.
- Jojoba seed meal is a by-product of the oil extraction of the seeds of the jojoba plant (Simmondsia chinensis or Californica), a native oilseed shrub of the Sonoran desert, including parts of Arizona, California and Mexico.
- the principal product extracted from the seeds is a liquid wax with characteristics similar to sperm whale oil. Jojoba oil is frequently applied as an additive in mineral oils and cosmetics.
- Defatted jojoba seed meal contains approximately 30% proteins, and its supplementation in animal feed has been reported as associated with food intake reduction and growth retardation (Booth, A. N., Elliger, C. A. and Wain, A. C., Jr., 1974. Isolation of a toxic factor from jojoba meal. Life Sci., 15: 1115-1120; Cokelaere, M. M., Buyse, J., Daenens, P., Decuypere, E., Kuhn, E. R. and Van Boven, M., 1993. Influence of jojoba seed meal supplementation on growth and organ function in rats. J. Agric. Food Chem., 41: 1444-1448).
- a companion pet is treated with a sufficient amount of a simmondsin component to provide from about 0.1% by weight of its daily dietary food dry matter mix to about 1.5% by weight of its daily dietary food dry matter mix of simmondsin activity.
- simmondsin activity refers to a simmondsin-containing component that is present at a sufficient level to provide from about 0.1% by weight of the total dietary daily dog food mix dry matter to about 1.5% by weight of the daily dietary dog food mix dry matter of pure simmondsin.
- the preferred range of simmondsin activity is within the range of 0.4% by weight of said daily dietary dog food mix dry matter to about 1.0% by weight of said daily dietary dog food mix dry matter.
- the simmondsin activity can be derived from jojoba seeds, defatted jojoba seed meal, from the pure compound simmondsin, from simmondsin-2′-ferulate, or from related cyanomethylene glycosides.
- the simmondsin component is from defatted jojoba seed meal.
- defatted jojoba seed meal is readily available, with it being a by-product of oil extraction process of the seeds of the jojoba plant. It is now normally discarded.
- the method of administration or treatment with the simmondsin component can be by simply admixture (on a weight basis sufficient to provide the desired simmondsin activity) with conventional pet foods.
- dry pet foods typically dry dog foods, normally contain protein, fat, fiber, non-fiber carbohydrates, minerals, vitamins and moisture components.
- major ingredients there are typically one or two cereal grains, generally corn, wheat and/or rice.
- cereal grains generally corn, wheat and/or rice.
- grain protein supplements such as corn gluten, soybean meal or other oil seed meals may be added.
- Typical nutrient content in the food dry matter will be as follows. Crude protein from 14% to 50%, usually 20% to 25%.
- Crude fat from 5% to 25%, with current obesity management (usually containing lower fat levels such as at 5% to 8% and with super premium brands usually containing from 14% to 20% fat).
- Crude fiber usually is present in the range of from about 3% to 14%, usually about 5% to 7%, with the total mineral or ash content being within the range of 3% to 10%, usually 4% to 7%.
- the important point is not the precise formulation of the pet food, since many conventional and satisfactory ones for use in conjunction with the present invention are available on the market. Rather, the key to success is that a sufficient amount of simmondsin component be added to pet food rations, whichever formulation is used, to provide the simmondsin activity level at the ranges previously expressed.
- the method of treating or administration is usually simple addition to the food prior to its extrusion or taming sufficient to provide the earlier-expressed simmondsin activity range, followed by free choice feeding of that food to the animal.
- pure simmondsin, simmondsin-2′-ferulate or other cyanomethylene glycosides could be administered by injection or in tablet or powder form.
- the most effective method is simple addition to normal food ration, since the result is to achieve a sufficient reduction in food intake to result in weight reduction and the prevention of obesity.
- simmondsin components herein mentioned could be used successfully with other species.
- simmondsin and/or its analogues and/or its derivatives can be used as a means for successful weight reduction and obesity prevention for humans.
- the examples set forth below show the effects of defatted jojoba seed meal in dog food for use in weight reduction to achieve obesity correction and prevention.
- a high-calorie, highly-palatable, low-fiber dry dog food as currently available on the market was used.
- the diet was typical of a super premium dry dog food and had the following guaranteed analysis: crude protein 24-26%; crude fat 16-18%; crude fiber 3-4.5%; ash 5-6.5%; and moisture 7-9%.
- Defatted jojoba seed meal at a 4.5% weight level (0.37% simmondsin activity) and at an 8% weight level (0.67% simmondsin activity) was added to the diets.
- Simmondsin activity in the jojoba seed meal used was calculated as its percent simmondsin plus its percent simmondsin-2′-female (S2F) times S2F's simmondsin content of 68%.
- the jojoba seed meal also contained 4.6% didemethyl simmondsin and 1.87% dimethyl simmondsin.
- the dogs selected for use in this study were known to be overeaters if a palatable diet was available. They were selected for use in this study because they were specifically the type in which sobesity is a problem. The dogs are identified in following table:
- Table II shows controlled dogs using Diet A, which contained no jojoba meal and simply was a diet without any added simmondsin activity.
- DIET A NO JOJOBA MEAL Dog g eaten/kg B. wt/day. No. Wk 1 Wk 2 Wk 3 Wk 4 19 33.2 30.8 22.8 23.1 53 46.0 29.1 26.1 25.5 W6 51.4 32.5 32.2 29.8 Avg. 43.5 30.8 27.0 26.1 28 g/kg/day eaten (excluding first week) Dog % Body Weight Change % Above Opt Wt No.
- Table II demonstrates that the diet by itself, without any added simmondsin activity, was palatable, and that even after becoming accustomed to having it available, all the dogs on this control diet continued to consume excess amounts and became obese.
- DIET D 4.5% JOJOBA MEAL (0.37% SIMMONDSIN ACTIVITY) g eaten/kg B. wt/day Dog No. Wk 1 Wk 2 Wk 3 11 20.0 19.9 18.7 30 20.4 16.4 19.1 31 34.7 22.2 18.9 40 23.8 16.5 17.3 43 23.4 18.8 22.1 54 25.6 22.9 24.1 55 24.4 23.4 24.5 45 19.4 21.2 — W5 16.4 17.4 — Avg. 23.1 19.8 20.7
- dogs voluntarily reduced their food intake from 28 to 20.25 g/kg body weight/day, a 27.6% reduction, when 4.5% jojoba seed meal by weight to provide 0.37% simmondsin activity was added to the food.
- dogs voluntarily reduced their food intake from 28 to 16.34 g/kg body wt./day, a 41.6% reduction, when 8% jojoba seed meal by weight providing 0.67% simmondsin activity was added to the food.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Animal Husbandry (AREA)
- Food Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Birds (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Physiology (AREA)
- Fodder In General (AREA)
- Feed For Specific Animals (AREA)
Abstract
A dog food composition containing a small but sufficient amount of simmondsin component to provide simmondsin within the range of 0.1% by weight of said dog food dry matter mix to about 1.5% by weight of said dog food dry matter mix. Also disclosed as part of the invention is a method of weight reduction of companion pets by adding to pet food the above-defined range of simmondsin, contributed by simmondsin, simmondsin analogues or mixtures thereof, such as derived from defatted jojoba seed meal, and thereafter feeding the pet food to a companion pet on a regular and sustained basis to achieve weight reduction then weight maintenance.
Description
Obesity is the most common nutritional disease of companion pets such as dogs and cats in an affluent society. It in fact exceeds by far all deficiency diseases combined. Obesity generally is considered present when body weight of the companion pet is 15% or more greater than optimum, which is the point at which health problems begin increasing with increasing weight. It has, for example, been reported that in affluent societies from 24% to 44% of the dogs are obese. Generally speaking, the incidence of obesity in companion pets increases with the age of the pet. Similar to humans, as the animals age body fat increases, and the amount of lean body mass decreases. For dogs particularly, obesity is more common in females than males up to age 12 years.
Because obesity develops gradually, the companion pet owner is often unaware of the overweight condition until it is called to his or her attention. Rarely is an animal presented to a veterinarian solely for the problem of obesity, but instead because of dermatitis, shortness of breath, routine immunizations, or arthritic or rheumatic symptoms. It is not uncommon that obesity is the predisposing cause of the condition noticed by the owner, although the obesity itself may not be noticed. For example, in one study it was observed that nearly one-third of the owners of obese dogs did not realize that their dogs were overweight.
The cause of obesity in companion pets is quite simple—energy intake in excess of that utilized. However, the factors causing this are not quite so simple. Some dogs are known to be “easy keepers”. That is, they become overweight while being fed commercial dog foods in amounts adequate for normal adult maintenance, and in the same amount and manner as their kennel mates who may maintain optimum weight.
In most instances, in companion pet obesity them an two stages—an initial phase and a static phase. The basic cause of the initial phase is a dietary energy intake in excess of that utilized, resulting in a positive energy balance which is deposited as fat. In the static phase, dietary intake is reduced in accordance with energy needs so that body weight remains constant in the obese state. Thus, the amount of food required to maintain the animal in obese state is no greater, and in fact is often less, than that required to maintain the normal, non-obese state.
Thus, the only successful way for reducing companion animals is a drastic food intake reduction. When this occurs, the companion pets often scavenge and/or beg for food because of the sensation of constant hunger. As a result, the animal finds additional food, or pet owners feed the animal to stop the begging with the result being that no weight reduction occurs.
In short, it can be seen that for companion pets successful weight reduction involves not only decreased food intake, but as well an interdisciplinary, psychological treatment that involves the interrelationship between the companion animal and its human owner. This complex psychological interdependency makes weight reduction in companion pets even more difficult than it otherwise might be. In short, success at pet weight reduction involves initially convincing the owner that weight reduction is needed; secondly, the animal's food intake must be decreased for a sustained and regular period of time sufficient for weight reduction to occur; and third, the animal must be inhibited from constant scavenging and/or begging which tempts the owner to give in and increase the food intake to stop the begging.
In the past, certain drugs have been used in the treatment of obesity in mammals, including companion pets. These include drugs which decrease appetite such as amphetamines, drugs which cause nausea, decrease intestinal absorption, or increase metabolic rate such as thyroid hormones and finally, drugs which either tranquilize or act as diuretics. None of the above have been generally effective. They often cause side effects, and tests of most have shown that such drugs are not only expensive, but ineffective in that when free choice fed with food, the animals often tend to avoid the food that contains the drug.
It therefore can be seen that there is a real and continuing need for a treatment for mammals, and especially companion pets, which is safe, efficacious, and which can successfully result in obesity reduction without changing the animal's behavioral patterns to such an extent that its relationship with its owner is changed. This invention has, as its primary objective, the fulfillment of this need.
A dog food composition containing a small but effective amount of simmondsin component to provide a simmondsin activity within the range of 0.1% by weight of said dog food mix dry matter to about 1.5% by weight of said dog food mix dry matter. Also, part of the invention is a method of weight reduction and obesity prevention of companion pets by adding pet food that contains the above-defined range of simmondsin activity, contributed by simmondsin analogues or mixtures thereof such as that synthesized or derived from jojoba seeds or defatted jojoba seed meal, and thereafter feeding the pet food to a companion pet on a regular and sustained basis until sufficient weight reduction occurs, and obesity occurrence or recurrence is prevented.
Jojoba seed meal is a by-product of the oil extraction of the seeds of the jojoba plant (Simmondsia chinensis or Californica), a native oilseed shrub of the Sonoran desert, including parts of Arizona, California and Mexico. The principal product extracted from the seeds is a liquid wax with characteristics similar to sperm whale oil. Jojoba oil is frequently applied as an additive in mineral oils and cosmetics.
Defatted jojoba seed meal contains approximately 30% proteins, and its supplementation in animal feed has been reported as associated with food intake reduction and growth retardation (Booth, A. N., Elliger, C. A. and Wain, A. C., Jr., 1974. Isolation of a toxic factor from jojoba meal. Life Sci., 15: 1115-1120; Cokelaere, M. M., Buyse, J., Daenens, P., Decuypere, E., Kuhn, E. R. and Van Boven, M., 1993. Influence of jojoba seed meal supplementation on growth and organ function in rats. J. Agric. Food Chem., 41: 1444-1448). These articles indicate that jojoba seed meal contains simmondsins and suggest that it may work to induce food intake reduction by a toxic mechanism, see particularly Booth et al., 1974. Cokelaere, et al., 1993 Journal of Agricultural Food Chemistry article, reports on the influence of jojoba seed meal supplementation on growth and organ function in rats. Other articles by Cokelaere, et al. report on the influence of pure simmondsin on food intake of rats and the effect on the fertility in rats after long-term jojoba seed meal supplementation, see Cokelaere, Influence of Pure Simmondsin on Food Intake in Rats, Journal of Agricultural Food Chemistry, 1992, 40; and Journal of Agricultural Food Chemistry, 1993, 41,1449-1451, Fertility in Rats After Long-Term Jojoba Meal Supplementation.
None of these articles suggest the use of jojoba seed meal or its simmondsin analogues in a sustained and regular weight reduction program for companion pets. It is understandable that the Cokelaere articles did not make such a suggestion since transfer of data from rat experiments to higher animals is not at all a certainty and, as well, there is a fundamental difference between successful weight reduction for companion pets and the mere observation that an active or potential active may cause food consumption reduction in some manner. For example, as illustrated in the tests hereinafter disclosed, food consumption reduction at levels within the range of 20% to 27% allows no weight reduction. Thus, for companion pets, and especially dogs, who are known to like a high calorie diet, a successful weight reduction program must involve food reduction at levels equal to or greater than 27%.
It has now surprisingly been discovered that, for reasons not yet completely understood, compounds that have simmondsin activity, and in particular defatted jojoba seed meal, when added to companion pet foods to achieve later defined levels of simmondsin activity, will successfully result in companion pet, and particularly dog, weight reduction. This is done without significantly changing the animal's behavior patterns, and importantly without changing the anima's psychological interrelationship with the pet owner. As a result, the companion pet avoids the frequent begging and/or food scavenging that destroys diet efforts and the animal will, without any significant side effects or behavior pattern changes, voluntarily practice eating habits that result in weight reduction.
In accordance with this invention, a companion pet is treated with a sufficient amount of a simmondsin component to provide from about 0.1% by weight of its daily dietary food dry matter mix to about 1.5% by weight of its daily dietary food dry matter mix of simmondsin activity. As used herein, simmondsin activity refers to a simmondsin-containing component that is present at a sufficient level to provide from about 0.1% by weight of the total dietary daily dog food mix dry matter to about 1.5% by weight of the daily dietary dog food mix dry matter of pure simmondsin. The preferred range of simmondsin activity is within the range of 0.4% by weight of said daily dietary dog food mix dry matter to about 1.0% by weight of said daily dietary dog food mix dry matter.
The simmondsin activity can be derived from jojoba seeds, defatted jojoba seed meal, from the pure compound simmondsin, from simmondsin-2′-ferulate, or from related cyanomethylene glycosides. Preferably, the simmondsin component is from defatted jojoba seed meal.
Presently, defatted jojoba seed meal is readily available, with it being a by-product of oil extraction process of the seeds of the jojoba plant. It is now normally discarded.
The method of administration or treatment with the simmondsin component can be by simply admixture (on a weight basis sufficient to provide the desired simmondsin activity) with conventional pet foods.
As those skilled in the art know, dry pet foods, typically dry dog foods, normally contain protein, fat, fiber, non-fiber carbohydrates, minerals, vitamins and moisture components. For example, as major ingredients there are typically one or two cereal grains, generally corn, wheat and/or rice. In addition, for a protein source they may contain poultry meal, by-product meat, meat and bone meal, or other animal or fish meal by-products. At times as well, grain protein supplements such as corn gluten, soybean meal or other oil seed meals may be added. Typical nutrient content in the food dry matter will be as follows. Crude protein from 14% to 50%, usually 20% to 25%. Crude fat from 5% to 25%, with current obesity management (usually containing lower fat levels such as at 5% to 8% and with super premium brands usually containing from 14% to 20% fat). Crude fiber usually is present in the range of from about 3% to 14%, usually about 5% to 7%, with the total mineral or ash content being within the range of 3% to 10%, usually 4% to 7%. The important point is not the precise formulation of the pet food, since many conventional and satisfactory ones for use in conjunction with the present invention are available on the market. Rather, the key to success is that a sufficient amount of simmondsin component be added to pet food rations, whichever formulation is used, to provide the simmondsin activity level at the ranges previously expressed.
The method of treating or administration is usually simple addition to the food prior to its extrusion or taming sufficient to provide the earlier-expressed simmondsin activity range, followed by free choice feeding of that food to the animal. However, it is conceivable that pure simmondsin, simmondsin-2′-ferulate or other cyanomethylene glycosides could be administered by injection or in tablet or powder form. However, it is currently believed that the most effective method is simple addition to normal food ration, since the result is to achieve a sufficient reduction in food intake to result in weight reduction and the prevention of obesity.
While tests have not yet been conducted on other companion pets or on other domestic livestock animals, it is conceivable and within the scope of the expected uses of the present invention that simmondsin components herein mentioned could be used successfully with other species. In fact, it is likely, although tests have not been conducted yet, that simmondsin and/or its analogues and/or its derivatives can be used as a means for successful weight reduction and obesity prevention for humans.
The following examples are offered to further illustrate, but not limit the invention.
The examples set forth below show the effects of defatted jojoba seed meal in dog food for use in weight reduction to achieve obesity correction and prevention. In these tests a high-calorie, highly-palatable, low-fiber dry dog food as currently available on the market was used. The diet was typical of a super premium dry dog food and had the following guaranteed analysis: crude protein 24-26%; crude fat 16-18%; crude fiber 3-4.5%; ash 5-6.5%; and moisture 7-9%. Defatted jojoba seed meal at a 4.5% weight level (0.37% simmondsin activity) and at an 8% weight level (0.67% simmondsin activity) was added to the diets. Simmondsin activity in the jojoba seed meal used was calculated as its percent simmondsin plus its percent simmondsin-2′-female (S2F) times S2F's simmondsin content of 68%. The jojoba seed meal also contained 4.6% didemethyl simmondsin and 1.87% dimethyl simmondsin. When 10 dogs were allowed to choose either the leading selling dry dog food or one of the diets containing defatted jojoba seed meal, all 10 dogs preferred the jojoba-containing diet (over 85% of the total amount eaten by each dog was one of the jojoba-containing diets). They consumed 31.1 times more of the 4.5% jojoba diet than they did of the leading selling dry dog food, 74.6 times more of the 8% jojoba diet than they did of the leading selling dry dog food, and 70.1 times more of the 8% jojoba diet than they did of the leading selling dry canine weight reduction diet (over 88% of the total amount eaten by each dog was the 8% jojoba diet). As evidenced from the testing shown below, simmondsin activity level of 0.37% provided by defatted jojoba seed meal added at a weight level of 4.5% of the dry dog food results in a sufficient voluntary reduction in food intake to result in maintenance of body weight by dogs that were previously known to be obese dogs and natural overeaters. The addition of defatted jojoba seed meal al the 9% by weight level which provides a simmondsin activity of 0.67% resulted in a sufficient voluntary reduction in food intake by most obese dogs to result in a 2% to 3% per week decrease in body weight. This is the rate of weight reduction most commonly recommended for obese dogs so that the pet owner notices the weight decrease, but it occurs without risk of causing any health problems in the animal. In addition, the data show that the animals do not reject the diet, but eat it regularly, seem to like it, and will continue eating it on a regular and sustained basis such as required for the desired weight reduction. Finally, no adverse effects to date in the tests have been noticed.
The dogs selected for use in this study were known to be overeaters if a palatable diet was available. They were selected for use in this study because they were specifically the type in which sobesity is a problem. The dogs are identified in following table:
| TABLE I |
| DOGS, DIET AND METHOD USED |
| Initial Body | Optimum | ||
| Weight | Wt— |
| Dog # | Breed Type | Lbs. | % > Opt | Lbs | Sex | Age |
| 11 | Beagle | 25.2 | 19.9 | 21.0 | F | 8 |
| 19 | Fox Terrier | 25.1 | 0 | 25.1 | F | 9 |
| 30 | Pug | 21.6 | 19.8 | 18.0 | M | 5 |
| 31 | Pug | 17.6 | 17.4 | 15.0 | M | 4 |
| 40 | English | 50.3 | 35.8 | 37.0 | F-S | 10 |
| Springer | ||||||
| Spaniel | ||||||
| 43 | Labrador | 80.5 | 23.8 | 65.0 | M | 8 |
| Retriever | ||||||
| 45 | Labrador | 79.5 | 20.5 | 66.0 | F | 8 |
| Retriever | ||||||
| 53 | Boxer | 58.7 | 2.7 | 55.0 | F | 7 |
| 54 | Labrador | 68.2 | 24.1 | 55.0 | F | 8 |
| Retriever | ||||||
| 55 | Labrador | 76.3 | 33.8 | 57.0 | M | 8 |
| Retriever | ||||||
| W5 | Vizsla | 115.5 | 28.4 | 90.0 | M-N | 6 |
| Cross | ||||||
| W6 | Labrador | 62.7 | (−10.3) | 70.0 | M | 5 |
| Retriever | ||||||
| Avg: | 55.5 | 16.4 | 47.8 | 7.2 | ||
Five diets of identical composition, except for varying amounts of defatted jojoba seed meal replacing wheat germ meal, were prepared at the same time, from the same batch of ingredients. All were similar in nutrient content, exceeding the dogs' requirements for all nutrients. The diets were all high in fat and caloric density, and low in fiber, which is the opposite in all aspects to currently-available obesity correction and prevention diets. These diets were used because the high fat content makes them especially palatable for the animal. All dogs always had water available, were allowed free access to their diet from 10:00 a.m. to 6:00 p.m. daily and were weighed at 9:00 a.m. once weekly. Food intake was measured daily. Each dog was given a thorough physical exam by a veterinarian before the study, after six weeks, and another at the end of the study.
Table II shows controlled dogs using Diet A, which contained no jojoba meal and simply was a diet without any added simmondsin activity.
| TABLE II |
| DIET A = NO JOJOBA MEAL |
| Dog | g eaten/kg B. wt/day. |
| No. | Wk 1 | Wk 2 | Wk 3 | Wk 4 |
| 19 | 33.2 | 30.8 | 22.8 | 23.1 |
| 53 | 46.0 | 29.1 | 26.1 | 25.5 |
| W6 | 51.4 | 32.5 | 32.2 | 29.8 |
| Avg. | 43.5 | 30.8 | 27.0 | 26.1 |
|
|
| 28 g/kg/day eaten (excluding first week) |
| Dog | % Body Weight Change | % Above Opt Wt |
| No. | Wk 1 | Wk 2 | Wk 3 | Wk 4 | Total | Initial | Final |
| 19 | +3.1 | +5.9 | (−1.8) | +1.6 | +8.9 | 0 | +8.9 |
| 53 | +11.5 | +2.4 | +0.4 | +0.2 | +14.9 | +2.7 | +18.0 |
| W6 | +10.8 | +5.8 | +4.4 | +5.5 | +29.1 | (−10.3) | +24.4 |
| Avg. | +8.5 | +4.7 | +1.0 | +2.4 | +17.6 | ||
|
|
|||
| average +2.7%/week | |||
| excluding first week | |||
| g/kg/ | % B. wt | % Above Optimum | ||
| Dog | day | change | Body weight on A |
| No. | Wk 1 | Wk 1 | Initial | Final |
| 45 | 36.6 | +6.0 | 13.6 | 20.5 |
| W5 | 28.5 | +10.5 | 16.1 | 28.3 |
| Avg. | 32.6 | +8.3 | 14.85 | 24.4 |
Table II demonstrates that the diet by itself, without any added simmondsin activity, was palatable, and that even after becoming accustomed to having it available, all the dogs on this control diet continued to consume excess amounts and became obese.
| TABLE III |
| DIET D = 4.5% JOJOBA MEAL (0.37% SIMMONDSIN ACTIVITY) |
| g eaten/kg B. wt/day |
| Dog No. | Wk 1 | Wk 2 | Wk 3 | ||
| 11 | 20.0 | 19.9 | 18.7 | ||
| 30 | 20.4 | 16.4 | 19.1 | ||
| 31 | 34.7 | 22.2 | 18.9 | ||
| 40 | 23.8 | 16.5 | 17.3 | ||
| 43 | 23.4 | 18.8 | 22.1 | ||
| 54 | 25.6 | 22.9 | 24.1 | ||
| 55 | 24.4 | 23.4 | 24.5 | ||
| 45 | 19.4 | 21.2 | — | ||
| W5 | 16.4 | 17.4 | — | ||
| Avg. | 23.1 | 19.8 | 20.7 | ||
As shown, excluding the first week, dogs voluntarily reduced their food intake from 28 to 20.25 g/kg body weight/day, a 27.6% reduction, when 4.5% jojoba seed meal by weight to provide 0.37% simmondsin activity was added to the food.
| TABLE IV |
| Diet D = 4.5% Jojoba Meal (0.3 to 0.4% Simmondsin Activity) |
| % Above | ||
| Dog | % Body Weight Change | Opt Wt |
| No. | Wk 1 | Wk 2 | Wk 3 | Wk 4 | Total | /wk | Initial | Final |
| 11 | −3.1 | −0.6 | +0.8 | — | −2.9 | −1.0 | 19.9 | 15.8 |
| 30 | −1.0 | −1.3 | −2.0 | +0.7 | −3.6 | −0.9 | 19.8 | 15.5 |
| 31 | +2.1 | −3.2 | −0.4 | — | −1.5 | −0.5 | 17.4 | 15.6 |
| 40 | −0.5 | +0.5 | −0.5 | — | −0.5 | −0.2 | 35.8 | 35.1 |
| 43 | +1.3 | −1.5 | +2.4 | — | +2.1 | +0.7 | 23.6 | 26.5 |
| 54 | +2.2 | +2.2 | −0.5 | — | +3.9 | +1.3 | 24.1 | 28.9 |
| 55 | +5.3 | −2.2 | +1.3 | — | +4.3 | +1.4 | 33.8 | 39.5 |
| 45 | 0.0 | −0.3 | — | — | −0.3 | −0.2 | 20.5 | 20.1 |
| W5 | −1.5 | +0.2 | — | — | −1.3 | −0.7 | 28.3 | 26.6 |
| Avg. | +0.5 | −0.7 | +0.16 | +0.7 | +0.2 | 24.8 | 24.8 | |
All the dogs using this diet, which differed from the Table II diet simply by the addition of 4.5% jojoba seed meal, maintained the dog's body weight even when they were allowed free access to this high energy, highly palatable diet containing 0.37% simmondsin activity. In contrast to dogs receiving the same diet without simmondsin activity, they did not continue to gain weight as the detailed evidence shows. It is worthy of note that these animals maintained weight even though they voluntarily decreased their food intake by an average of 27.6%.
In the study shown in Table V the same diet was used, except that the amount of simmondsin activity was increased to 0.67% by increasing the amount of the defatted jojoba seed meal to 8% of the diet by weight.
| TABLE V |
| Diet E = 8.0% Jojoba Meal (0.67% Simmondsin Activity) |
| Dog | g/kg body weight/day eaten |
| No. | Wk 1 | Wk 2 | Wk 3 | Wk 4 | Wk 5 |
| 11 | 15.5 | 15.2 | 15.5 | 14.5 | 15.6 |
| 30 | 14.0 | 10.1 | 15.1 | 7.4 | |
| 31 | 17.4 | 17.5 | 23.4 | 17.8 | 19.2 |
| 40 | 12.4 | 12.8 | 12.2 | 11.8 | 10.9 |
| 43 | 16.3 | 19.2 | 15.9 | 17.8 | 20.0 |
| 54 | 17.6 | 14.7 | 16.7 | 12.2 | 18.7 |
| 55 | 25.9 | 19.8 | 18.9 | 19.9 | 17.3 |
| 45 | 16.5 | 14.7 | 15.0 | 18.3 | 18.2 |
| W5 | 14.7 | 13.2 | 14.1 | 13.5 | 10.8 |
| 53 | 20.7 | 20.9 | 18.5 | 19.1 | |
| W6 | 15.2 | 16.5 | 16.9 | 15.4 | |
| Avg. | 16.9 | 15.9 | 16.6 | 16.0 | 16.3 = 16.34 g/kg |
| B. Wt./day eaten | |||||
As shown, dogs voluntarily reduced their food intake from 28 to 16.34 g/kg body wt./day, a 41.6% reduction, when 8% jojoba seed meal by weight providing 0.67% simmondsin activity was added to the food.
| TABLE VI |
| Diet E = 8.0% Jojoba Meal (0.5 to 0.7% Simmondsin Activity) |
| % Above | ||
| or Below | ||
| % Body Weight change | Opt. Wt. |
| Dog | Wk. | Wk. | Wk. | Wk. | Wk. | ||||
| No. | 1 | 2 | 3 | 4 | 5 | Total | /Wk | Initial | Final |
| 11 | −5.0 | −2.7 | −0.8 | −1.0 | −3.4 | −12.2 | −2.4 | +15.8 | +2.2 |
| 30 | −2.3 | −4.4 | −0.2 | −7.2 | −15.2 | −3.8 | +15.2 | 0.0 | |
| 31 | −4.5 | −2.9 | −5.9 | −1.6 | −5.4 | −19.5 | −3.9 | +15.6 | (−6.9) |
| 40 | −4.0 | −1.9 | −1.2 | −5.4 | +0.7 | −11.4 | −2.3 | +35.2 | +19.7 |
| 43 | −1.5 | +0.5 | +1.1 | −2.1 | +1.3 | +0.6 | +0.1 | +24.4 | +25.4 |
| 54 | −0.6 | −2.8 | −1.5 | −2.4 | +1.7 | −5.5 | −1.1 | +28.9 | +21.8 |
| 55 | +3.5 | −2.0 | −0.8 | +0.9 | −2.5 | −0.9 | −0.2 | +39.5 | +38.2 |
| 45 | −0.9 | −1.2 | +0.5 | −3.8 | +1.3 | −4.1 | −0.8 | +20.1 | +15.2 |
| W5 | +0.5 | −1.7 | −1.9 | −0.5 | −1.4 | −4.8 | −1.0 | +26.7 | +20.6 |
| 53 | −5.6 | −5.8 | −3.5 | −7.6 | −20.6 | −5.2 | +18.0 | (−6.4) | |
| W6 | −6.4 | −2.7 | −1.7 | −2.1 | −12.4 | −3.1 | +15.8 | +1.6 | |
| Avg. | −2.44 | −2.51 | −1.45 | −2.98 | −0.96 | −9.7 | −2.2 | +23.2 | +11.9 |
As can be seen, most obese dogs using the 0.67% simmondsin activity food on a free choice basis voluntarily reduce their food intake an average of 41.6% when fed this diet, an amount sufficient to lose weight at the widely recommended rate of 2% to 3% per week. In addition, when dogs were allowed free access to the 0.37% simmondsin activity food, they were able to maintain a relatively steady weight while voluntarily decreasing their food intake an average of 27.6%. Moreover, the animals exhibited no changes in behavior and no adverse health effects during the tests. It therefore can be seen that the invention accomplishes all of its stated objectives.
Claims (2)
1. A method of weight loss and weight maintenance in a dog, comprising:
feeding a dog a simmondain component, a simmondsin analogue, or a mixture thereof, sufficient to provide the dog pure simmondsin within the range of from about 0.4%-1.0% by weight of dog food dry matter mix until the dog reaches its target weight; and then
feeding the dog a simmondsin component, a simmondsin analogue, or a mixture thereof, sufficient to provide the dog pure simmondbin within the range from about 0.1% by weight of dog food dry matter mix to about 0.37% by weight of dog food dry matter mix to maintain the dog's target weight.
2. The method of claim 1 wherein the simmondsin analogue is simmondsin-2′-ferulate or cyanomethylene glycosides.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/975,334 USRE38155E1 (en) | 1996-02-29 | 2001-10-12 | Weight reduction method for dogs and other pets |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/608,766 US5962043A (en) | 1996-02-29 | 1996-02-29 | Weight reduction method for dogs and other pets |
| US09/975,334 USRE38155E1 (en) | 1996-02-29 | 2001-10-12 | Weight reduction method for dogs and other pets |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US08/608,766 Reissue US5962043A (en) | 1996-02-29 | 1996-02-29 | Weight reduction method for dogs and other pets |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| USRE38155E1 true USRE38155E1 (en) | 2003-06-24 |
Family
ID=24437893
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US08/608,766 Ceased US5962043A (en) | 1996-02-29 | 1996-02-29 | Weight reduction method for dogs and other pets |
| US09/975,334 Expired - Lifetime USRE38155E1 (en) | 1996-02-29 | 2001-10-12 | Weight reduction method for dogs and other pets |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US08/608,766 Ceased US5962043A (en) | 1996-02-29 | 1996-02-29 | Weight reduction method for dogs and other pets |
Country Status (1)
| Country | Link |
|---|---|
| US (2) | US5962043A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050222050A1 (en) * | 2004-03-17 | 2005-10-06 | Nestec S.A. | Compositions and methods for reducing or preventing obesity |
| US20070110789A1 (en) * | 2005-11-02 | 2007-05-17 | Nestec, S. A. | Isoflavone compositions for reducing accumulation of body fat in male mammals, and methods for their use |
| US20070231370A1 (en) * | 2004-06-09 | 2007-10-04 | Thomas Gastner | Guanidino Acetic Acid Used as an Animal Food Additive |
| US20150173399A1 (en) * | 2013-12-19 | 2015-06-25 | Nestec Sa | Compositions and methods for increasing palatability of dry pet food |
Families Citing this family (62)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6746695B1 (en) | 1998-10-02 | 2004-06-08 | Armadillo Pharmaceuticals, Inc. | Pharmaceutical preparations of bioactive substances extracted from natural sources |
| US6737089B2 (en) | 1999-08-27 | 2004-05-18 | Morinda, Inc. | Morinda citrifolia (Noni) enhanced animal food product |
| AU2001274355B2 (en) * | 2000-03-22 | 2006-06-29 | Societe Des Produits Nestle S.A. | Pet food composition and method of manufacture |
| US20040192761A1 (en) * | 2003-03-25 | 2004-09-30 | Palu Afa Kehaati | Preventative and treatment effects of morinda citrifolia as an aromatase inhibitor |
| US6855345B2 (en) * | 2001-11-02 | 2005-02-15 | Morinda, Inc. | Preventative and treatment effects of Morinda citrifolia on diabetes and its related conditions |
| US20110217394A1 (en) * | 2000-12-05 | 2011-09-08 | Brett Justin West | Iridoid Based Formulations |
| US20070196527A1 (en) * | 2006-02-23 | 2007-08-23 | Jensen Claude J | Preventative and treatment effects of Morinda citrifolia on Osteoarthritis and its related conditions |
| US7244463B2 (en) * | 2005-10-18 | 2007-07-17 | Tahitian Noni International, Inc. | Garcinia mangostana L. enhanced animal food product |
| US20110171333A1 (en) * | 2000-12-05 | 2011-07-14 | Bryant Wadsworth | Morinda Citrifolia Based Antioxidant and Antimicrobial Formulations for Improved Color Stability and Increased Shelf Life of Various Meat Products |
| US7048952B2 (en) * | 2002-05-21 | 2006-05-23 | Morinda, Inc. | Formulation for inhibiting fungal and microbial growth comprising morinda citrifolia puree juice |
| US8574642B2 (en) | 2000-12-05 | 2013-11-05 | Tahitian Noni International, Inc. | Antiviral Morinda citrifolia L. based formulations and methods of administration |
| US20120237626A9 (en) * | 2000-12-05 | 2012-09-20 | Palu Afa Kehaati | Profiles of lipid proteins and inhibiting HMG-CoA reductase |
| US8652546B2 (en) | 2007-09-06 | 2014-02-18 | Tahitian Noni International, Inc. | Morinda citrifolia based formulations for regulating T cell immunomodulation in neonatal stock animals |
| US8790727B2 (en) * | 2000-12-05 | 2014-07-29 | Tahitian Noni International, Inc. | Morinda citrifolia and iridoid based formulations |
| FR2819382B1 (en) * | 2001-01-17 | 2004-12-24 | Royal Canin Sa | DRY FOOD FOR CONTROLLING PONDERAL OVERLOAD AND DOG OBESITY |
| EP1389124A4 (en) * | 2001-04-17 | 2004-12-15 | Morinda Inc | PALLIATIVE EFFECTS OF I MORINDA CITRIFOLIA / I JUICE AND OIL |
| EP1277412A1 (en) * | 2001-07-17 | 2003-01-22 | Societe Des Produits Nestle S.A. | Pet food composition for regulating body weight and preventing obesity and related disorders in pets |
| US6620442B2 (en) * | 2001-08-24 | 2003-09-16 | International Flora Technologies, Inc. | Simmondsin processing methods and products |
| WO2003017779A1 (en) * | 2001-08-28 | 2003-03-06 | Mcdog Pet-Products, S.L. | Meat product for feeding animals |
| US20050084550A1 (en) * | 2001-09-08 | 2005-04-21 | International Flora Technologies | Weight reduction and maintenance method for animals |
| CN1589155B (en) * | 2001-10-05 | 2010-05-26 | 鲁比康科学有限公司 | Animal feed containing active substance and method of use |
| US6866862B2 (en) * | 2001-10-05 | 2005-03-15 | Rubicon Scientific | Animal feeds including heartworm-prevention drugs |
| US7052712B2 (en) * | 2001-10-05 | 2006-05-30 | Rubicon Scientific Llc | Animal feeds including actives and methods of preparing same |
| US6716448B2 (en) | 2001-10-05 | 2004-04-06 | Rubicon Scientific Llc | Domesticated household pet food including maintenance amounts of ivermectin |
| US7070813B2 (en) * | 2001-11-02 | 2006-07-04 | Morinda, Inc. | Preventative and treatment effects of morinda citrifolia as a colon cancer cell growth inhibitor |
| US7442395B2 (en) * | 2002-11-14 | 2008-10-28 | Tahitian Noni International, Inc. | Formulation for treating candidiasis using Morinda citrifolia |
| US20110160057A1 (en) * | 2001-11-14 | 2011-06-30 | Bryant Wadsworth | Morinda Citrifolia Based Antimicrobial Formulations |
| US7138134B2 (en) * | 2001-12-18 | 2006-11-21 | Arizona Health Consulting Group, Llc | Preparation and administration of jojoba product for reducing weight, fat and blood lipid levels |
| US20030138547A1 (en) * | 2002-01-22 | 2003-07-24 | Mars, Incorporated | Weight management system for animals |
| AU2003205279B2 (en) * | 2002-01-22 | 2007-08-23 | Mars, Incorporated | Weight management system for obese animals |
| US6852342B2 (en) * | 2002-03-26 | 2005-02-08 | Avoca, Inc. | Compounds for altering food intake in humans |
| US20030194423A1 (en) | 2002-04-15 | 2003-10-16 | Mars, Inc. | Composition for enhancing nutritional content of food |
| US20060269630A1 (en) * | 2003-04-16 | 2006-11-30 | Palu Afa K | Morinda citrifolia as a 5-Lipoxygenase inhibitor |
| US20050106275A1 (en) * | 2003-05-02 | 2005-05-19 | Chen Su | Morinda citrifolia-based formulation for inhibiting metastasis of carcinogenic cells |
| JP4073826B2 (en) * | 2003-06-04 | 2008-04-09 | タヒチアン ノニ インターナショナル インコーポレーテッド | Agricultural vital agent containing extract of Yaeyama Aoki |
| US20060105066A1 (en) * | 2003-07-22 | 2006-05-18 | Avoca, Inc. | Compounds for altering food intake in humans |
| US20070259060A1 (en) * | 2003-08-12 | 2007-11-08 | Mian-Ying Wang | Formulations and Methods for Treating Breast Cancer with Morinda Citrifolia and Methylsulfonymethane |
| US8877178B2 (en) | 2003-12-19 | 2014-11-04 | The Iams Company | Methods of use of probiotic bifidobacteria for companion animals |
| US20050158294A1 (en) | 2003-12-19 | 2005-07-21 | The Procter & Gamble Company | Canine probiotic Bifidobacteria pseudolongum |
| US20050260291A1 (en) * | 2004-03-10 | 2005-11-24 | Palu Afa K | Methods and compositions for reactivating acetylcholinesterase |
| US20060088611A1 (en) * | 2004-09-01 | 2006-04-27 | Paulus Wang | Morinda citrifolia-based formulations and methods for weight management |
| US20060141076A1 (en) * | 2004-11-01 | 2006-06-29 | Palu Afa K | Morinda citrifolia based compositions and methods for inhibiting xanthine oxidase |
| US20060204601A1 (en) * | 2005-03-09 | 2006-09-14 | Palu Afa K | Formulations and methods for preventing and treating substance abuse and addiction |
| US20060280818A1 (en) * | 2005-05-26 | 2006-12-14 | Palu Afa K | Nicotinic acetylcholine receptor antagonist |
| US20070122507A1 (en) * | 2005-05-26 | 2007-05-31 | Palu Afa K | Histone deacetylase and tumor necrosis factor converting enzyme inhibition |
| EP1885383B1 (en) | 2005-05-31 | 2016-09-21 | IAMS Europe B.V. | Feline probiotic bifidobacteria |
| EP2261323A1 (en) | 2005-05-31 | 2010-12-15 | The Iams Company | Feline probiotic lactobacilli |
| US20070154579A1 (en) * | 2005-11-29 | 2007-07-05 | Palu Afa K | Morinda Citrifolia Based Formulation And Methods For Weight Management |
| US20070237848A1 (en) * | 2005-12-21 | 2007-10-11 | Brad Rawson | MORINDA CITRIFOLIA BASED COMPOSITIONS FOR TREATMENT OF ANTI-INFLAMMATORY DISEASES THROUGH INHIBITION OF COX-1, COX-2, INTERLEUKIN-1beta, INTERLEUKIN-6, TNF-alpha, HLE, AND iNOS |
| US20070281903A1 (en) * | 2006-05-04 | 2007-12-06 | Palu Afa K | Morinda Citrifolia-Based Formulation 5-LOX And 15-LOX |
| US8535741B2 (en) | 2006-05-12 | 2013-09-17 | Morinda, Inc. | Method and composition for administering bioactive compounds derived from Morinda citrifolia |
| US8025910B2 (en) | 2006-05-12 | 2011-09-27 | Tahitian Noni International, Inc. | Method and composition for administering bioactive compounds derived from Morinda citrifolia |
| US20080226758A1 (en) * | 2006-11-28 | 2008-09-18 | Shixin Deng | Lipoxygenase and Cyclooxygenase Inhibition |
| EP2124966B1 (en) | 2007-02-01 | 2015-09-09 | IAMS Europe B.V. | Method for decreasing inflammation and stress in a mammal using glucose antimetabolites, avocado or avocado extracts |
| US20080213415A1 (en) * | 2007-02-08 | 2008-09-04 | Palu Afa K | Treatment of Glaucoma and Diabetic Retinopathy with Morinda Citrifolia Enhanced Formulations |
| US20080317890A1 (en) * | 2007-06-21 | 2008-12-25 | Claude Jarakae Jensen | Method for treating visual impairment through the prophylactic administration of a morinda citrifolia-based naturaceutical |
| US20090196944A1 (en) * | 2008-02-01 | 2009-08-06 | Brad Rawson | Methods of Manufacture of Morinda Citrifolia Based Compositions for Treatment of Anti-Inflammatory Diseases through Inhibition of Cox-1, Cox-2, Interleukin -1beta, Interleukin-6, TNF-alpha, HLE, and iNOS |
| US9771199B2 (en) * | 2008-07-07 | 2017-09-26 | Mars, Incorporated | Probiotic supplement, process for making, and packaging |
| US10104903B2 (en) | 2009-07-31 | 2018-10-23 | Mars, Incorporated | Animal food and its appearance |
| US20110206786A1 (en) * | 2010-02-23 | 2011-08-25 | Brett Justin West | Acai and Iridoid Based Formulations |
| AU2014228552A1 (en) | 2013-03-15 | 2015-10-08 | Mars, Incorporated | Composition and method for preventing, reducing, alleviating, or treating idiopathic vomiting |
| CA2903907C (en) | 2013-03-15 | 2022-10-18 | The Iams Company | Composition and method for preventing, reducing, alleviating or treating idiopathic vomiting |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4310558A (en) * | 1980-01-21 | 1982-01-12 | Ralston Purina Company | Extruded fiber mixture pet food |
| US5141755A (en) * | 1991-05-29 | 1992-08-25 | Weisman Eric H | Reduced animal product pet food composition |
| WO1994025035A1 (en) * | 1993-04-29 | 1994-11-10 | K.U. Leuven Research & Development | Use of simmondsine |
-
1996
- 1996-02-29 US US08/608,766 patent/US5962043A/en not_active Ceased
-
2001
- 2001-10-12 US US09/975,334 patent/USRE38155E1/en not_active Expired - Lifetime
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4310558A (en) * | 1980-01-21 | 1982-01-12 | Ralston Purina Company | Extruded fiber mixture pet food |
| US5141755A (en) * | 1991-05-29 | 1992-08-25 | Weisman Eric H | Reduced animal product pet food composition |
| WO1994025035A1 (en) * | 1993-04-29 | 1994-11-10 | K.U. Leuven Research & Development | Use of simmondsine |
Non-Patent Citations (6)
| Title |
|---|
| Arnouts S, et al, Poultry Sci 72: 1714-21, 1993.* * |
| Cokelaere et al, "Fertility in Rats After Long-Term Jojoba Meal Supplementation", J. Agric. Food Chem., pp. 1449-1451, 1993.* * |
| Cokelaere et al, "Influence of Jojoba Meal Supplementation on Growth and Organ Function in Rats", J. Agric. Food Chem., vol. 42, pp. 1444-1448, 1993.* * |
| Cokelaere et al, "Influence of Pure Simmondsin on the Food Intake in Rats", J. Agric. Food Chem., vol. 40, pp. 1839-1842, 1992.* * |
| Cokelaere et al., "Evidences for a Satiating Effect of Defatted Jojoba Meal", Industrial Crops and Products 4, pp. 91-96, 1995. * |
| Manos CG, et al, J. Agric. Food Chem. 34:801-804, 1986.* * |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050222050A1 (en) * | 2004-03-17 | 2005-10-06 | Nestec S.A. | Compositions and methods for reducing or preventing obesity |
| US8193240B2 (en) | 2004-03-17 | 2012-06-05 | Nestec S.A. | Compositions and methods for reducing or preventing obesity |
| US20070231370A1 (en) * | 2004-06-09 | 2007-10-04 | Thomas Gastner | Guanidino Acetic Acid Used as an Animal Food Additive |
| US8501810B2 (en) | 2004-06-09 | 2013-08-06 | Alzchem Trostberg Gmbh | Guanidino acetic acid used as an animal food additive |
| US20070110789A1 (en) * | 2005-11-02 | 2007-05-17 | Nestec, S. A. | Isoflavone compositions for reducing accumulation of body fat in male mammals, and methods for their use |
| US8226973B2 (en) | 2005-11-02 | 2012-07-24 | Nestec, S. A. | Isoflavone compositions for reducing accumulation of body fat in male mammals, and methods for their use |
| US9427002B2 (en) | 2005-11-02 | 2016-08-30 | Nestec S.A. | Isoflavone compositions for reducing accumulation of body fat in male mammals, and methods for their use |
| US20150173399A1 (en) * | 2013-12-19 | 2015-06-25 | Nestec Sa | Compositions and methods for increasing palatability of dry pet food |
Also Published As
| Publication number | Publication date |
|---|---|
| US5962043A (en) | 1999-10-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| USRE38155E1 (en) | Weight reduction method for dogs and other pets | |
| EP1109457B1 (en) | Method to manufacture a composition to protect an obligate carnivore from a disease of abnormal carbohydrate metabolism | |
| US20100203174A1 (en) | Pet food composition for regulating body weight and preventing obesity and related disorders in pets | |
| JP2000116337A (en) | Pet food | |
| US6245364B1 (en) | Weight reduction method for cats and other pets | |
| Merkel et al. | Intake, digestibility and nitrogen utilization of three tropical tree legumes: II. As protein supplements | |
| Cardon et al. | The use of salt as a regulator of supplemental feed intake and its effect on the health of range livestock | |
| Heuser | Feeding poultry | |
| KR20090074151A (en) | Dry food for appetite loss | |
| Edwards | Feeding Organic Pigs: a handbook of raw materials and recommendations for feeding practice | |
| Wiseman et al. | Growing calf intake of hay or crop residue based diets | |
| US20080057094A1 (en) | Feeds and mineral supplements with insect repellant properties and methods of making and using | |
| USRE38167E1 (en) | Weight reduction method for cats and other pets | |
| Perez-Llamas et al. | The influence of clenbuterol on growth in rats | |
| Abdelgader et al. | Effect of beet molasses as a source of energy on performance of broiler chickens | |
| Dutcher | The nature and function of the antineuritic vitamine | |
| Lukefahr | Feeds and feeding. | |
| Ochefu et al. | Gastrointestinal Tract Morphometry And Visceral Organ Weights Of Grower Rabbit Fed Dried Ginger (Zingiber officinale) Root Meal In | |
| Mallam et al. | Effects of Breed and Inclusion Levels of Sun-Dried Pineapple Peel on Growth Performance of Growing Rabbit Bucks | |
| EP0070016A1 (en) | Method and composition for increasing reproduction in mammalian and avian species | |
| Sahu et al. | An Overview on Nutritional Deficiencies in Swine Production | |
| Pate et al. | Guidelines to selecting a liquid feed for winter supplementation of producing beef cows in south Florida | |
| Wagner | Improving performance of cattle consuming medium or low quality forages | |
| Ravindran | Methodology to evaluate the nutritive value of feedstuffs for poultry and swine | |
| Chambers | The effects of two meal supplements on the progress of calves receiving autumn grass |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FPAY | Fee payment |
Year of fee payment: 8 |
|
| FPAY | Fee payment |
Year of fee payment: 12 |
